The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C

Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2010.10.047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Side Effects of Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis-C

Internal Medicine
Internal MedicineMedicine
2007English

Cost Effectiveness of Interferon or Peginterferon With Ribavirin for Histologically Mild Chronic Hepatitis C

Gut
Gastroenterology
2006English

Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection

Eastern Mediterranean Health Journal
Medicine
2011English

Influence of HMG-CoA Reductase Inhibitor to Virological Response of Peginterferon/Ribavirin Combination Therapy in Chronic Hepatitis C

Acta Hepatologica Japonica
Hepatology
2008English

Incidence of and Risk Factors for Thyroid Dysfunction During Peginterferon Α and Ribavirin Treatment in Patients With Chronic Hepatitis C

Korean Journal of Internal Medicine
Internal Medicine
2015English

Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C

Gastroenterology
HepatologyGastroenterology
2011English

Peginterferon Alfa-2a in Patients With Chronic Hepatitis C and Cirrhosis

New England Journal of Medicine
Medicine
2000English

Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1

American Journal of Gastroenterology
HepatologyGastroenterology
2012English

Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy